GlassScriptPhysician profile
Michael R Prendergast
NPI 1568570158
$4,658.47
in general payments reported to CMS, 2019-2025
28 companies · $791 in 2025
The $791 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,219 · 2020: $178 · 2021: $448 · 2022: $462 · 2023: $449 · 2024: $111 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $791 · Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $791.26 |
| Food and Beverage | $560.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $1,408.84 | 2019 | |
| Abbott Laboratories | $948.44 | 2023-2025 | Esprit, Mitraclip |
| Silk Road Medical, INC. | $412.59 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Terumo Medical Corporation | $399.12 | 2019-2020 | |
| Medtronic, INC. | $203.67 | 2022 | |
| Medline Industries LP | $159.39 | 2019-2020 | |
| Cook Medical LLC | $150.70 | 2021 | |
| Shockwave Medical, INC | $147.92 | 2021 | |
| Bard Peripheral Vascular, INC. | $126.72 | 2023-2024 | Lutonix Drug Coated Balloon, Lifestream |
| Smith+Nephew, INC. | $118.75 | 2019-2021 | |
| Boston Scientific Corporation | $91.97 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $67.62 | 2021 | |
| Lemaitre Vascular, INC. | $67.36 | 2022 | |
| Next Science LLC | $55.91 | 2023 | Surgx, Blastx, Xperience |
| Braintree Laboratories, INC. | $43.23 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $28.11 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Covidien LP | $27.43 | 2019-2020 | |
| Allergan, INC. | $24.94 | 2019 | |
| Osiris Therapeutics INC. | $22.44 | 2019 | |
| Csl Behring | $22.17 | 2019 | |
| Biocompatibles, INC. | $21.20 | 2019 | |
| Z-Medica, LLC | $20.27 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.90 | 2023 | Lifevest |
| Merck Sharp & Dohme LLC | $16.88 | 2019 | |
| Reprise Biomedical, INC. | $14.55 | 2020 | |
| Organogenesis INC. | $13.15 | 2021 | |
| Biogen, INC. | $12.95 | 2020 | |
| Integra Lifesciences Corporation | $12.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Prendergast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.